Thursday 18th Aug, 2022

Dandenong manufacturer wins ‘landmark’ Panadol deal

Photo: GlaxoSmithKline

Pharmaceuticals manufacturer Aspen Australia will expand its Dandenong facility after winning a deal to supply Panadol products to Australia, South East Asia, the Middle East, North Africa and New Zealand.

The major deal means Aspen Australia will produce over 1.3 million Panadol tablets a day, along with 6.7 million bottles and tubes per annum.

As a result, the Victorian Department of Economic Development, Jobs, Transport and Resources said Aspen Australia was creating 85 new jobs in Dandenong.

“The investment is a significant win for Victoria’s pharmaceuticals industry,” the Department said in a short statement.

“The Victorian Government worked with Aspen Australia to win the landmark contract to produce Panadol, which will see it undertake a major expansi0on of its facility in Dandenong.

“The investment will further boost pharmaceutical exports, which were up 40 percent in 2017, and highlights the success Victoria is having in attracting investments that create local jobs.”

Panadol is a range of paracetamol tablets, designed to relieve pain including headaches, migraines, toothaches, cold and flu symptoms, muscle aches, arthritis, backaches and period pain.

A brand of pharmaceutical giant GlaxoSmithKline, the standard Panadol tablet is manufactured round and with a film coating, designed to make it easier to swallow and absent of a bitter aftertaste.